The links between obesity, insulin resistance, and immune function have provided the basis for the emerging field of immunometabolism which implicates immune cell infiltration and increased expression of inflammatory mediators such as TNFα and IL‐1β in the pathophysiology of metabolic disease (Ahima 2011). The gene discussed is TNF; the disease is obesity disorder.